• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达γ干扰素的重组柯萨奇病毒B3变异体的保护能力特性分析

Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.

作者信息

Henke Andreas, Jarasch Nadine, Martin Ulrike, Zell Roland, Wutzler Peter

机构信息

Institute of Virology and Antiviral Therapy, Medical Center, Friedrich Schiller University, Jena, Germany.

出版信息

Viral Immunol. 2008 Mar;21(1):38-48. doi: 10.1089/vim.2007.0077.

DOI:10.1089/vim.2007.0077
PMID:18355121
Abstract

Several different procedures have been developed to deliver essential genes to an organism by viral vectors. Some reports have already been published demonstrating the potential to use enteroviruses as transfer vehicles. One application of these viral vectors is the organ-specific expression of immunoregulatory cytokines. It has been shown previously that local expression of interferon-gamma (IFN-gamma) by the recombinant coxsackievirus CVB3/IFN-gamma conferred protection against virus-caused disease via direct and indirect mechanisms. Using a murine model of CVB3-induced myocarditis, other aspects of the CVB3/IFN-gamma application as a vaccine were studied concerning route of administration, age, and presence of a pre-existing immune response.

摘要

已经开发出几种不同的程序,通过病毒载体将必需基因传递给生物体。已经发表了一些报告,证明了使用肠道病毒作为传递载体的潜力。这些病毒载体的一个应用是免疫调节细胞因子的器官特异性表达。先前已经表明,重组柯萨奇病毒CVB3/干扰素-γ(IFN-γ)在局部表达干扰素-γ可通过直接和间接机制预防病毒引起的疾病。利用CVB3诱导的心肌炎小鼠模型,研究了CVB3/IFN-γ作为疫苗应用的其他方面,包括给药途径、年龄和预先存在的免疫反应。

相似文献

1
Characterization of the protective capability of a recombinant coxsackievirus B3 variant expressing interferon-gamma.表达γ干扰素的重组柯萨奇病毒B3变异体的保护能力特性分析
Viral Immunol. 2008 Mar;21(1):38-48. doi: 10.1089/vim.2007.0077.
2
Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.用于预防和治疗病毒诱导性心脏病的重组柯萨奇病毒载体
Int J Med Microbiol. 2008 Jan;298(1-2):127-34. doi: 10.1016/j.ijmm.2007.08.010. Epub 2007 Sep 25.
3
Coxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.柯萨奇病毒B3疫苗:用作预防心肌炎的表达载体。
Expert Rev Vaccines. 2008 Dec;7(10):1557-67. doi: 10.1586/14760584.7.10.1557.
4
Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.重组柯萨奇病毒B3变异体对免疫调节细胞因子的表达赋予了针对病毒引起的心肌炎的保护作用。
J Virol. 2001 Sep;75(17):8187-94. doi: 10.1128/jvi.75.17.8187-8194.2001.
5
Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.柯萨奇病毒 B3 病毒样颗粒疫苗接种可诱导体液免疫应答并保护小鼠免受心肌炎。
Vaccine. 2012 Mar 16;30(13):2301-8. doi: 10.1016/j.vaccine.2012.01.061. Epub 2012 Jan 31.
6
AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.AIM2与VP1共免疫与记忆性CD8 T细胞增加相关,并对柯萨奇病毒B3攻击产生持久保护。
Front Cell Infect Microbiol. 2017 Jun 8;7:247. doi: 10.3389/fcimb.2017.00247. eCollection 2017.
7
Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.双功能蛋白FimH的掺入增强了壳聚糖-pVP1疫苗对柯萨奇病毒B3诱导的心肌炎的免疫保护作用。
Antiviral Res. 2017 Apr;140:121-132. doi: 10.1016/j.antiviral.2017.01.020. Epub 2017 Jan 28.
8
Interferon-gamma-induced activation of nitric oxide-mediated antiviral activity of macrophages caused by a recombinant coxsackievirus B3.重组柯萨奇病毒B3诱导的γ干扰素激活巨噬细胞的一氧化氮介导的抗病毒活性。
Viral Immunol. 2005;18(2):355-64. doi: 10.1089/vim.2005.18.355.
9
Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.壳聚糖包裹的高迁移率族蛋白B1黏膜免疫增强DNA疫苗诱导的针对柯萨奇病毒B3所致心肌炎的保护作用。
Clin Vaccine Immunol. 2013 Nov;20(11):1743-51. doi: 10.1128/CVI.00466-13. Epub 2013 Sep 11.
10
Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.壳聚糖颗粒包裹的淋巴细胞趋化因子基因经鼻联合免疫增强对柯萨奇病毒B3诱导的心肌炎的抵抗力
Virology. 2009 Apr 10;386(2):438-47. doi: 10.1016/j.virol.2009.01.029. Epub 2009 Feb 23.

引用本文的文献

1
Autoimmune Heart Disease: A Comprehensive Summary for Forensic Practice.自身免疫性心脏病:法医实践的综合总结。
Medicina (Kaunas). 2023 Jul 25;59(8):1364. doi: 10.3390/medicina59081364.
2
Vaccines against Group B Coxsackieviruses and Their Importance.抗B组柯萨奇病毒疫苗及其重要性。
Vaccines (Basel). 2023 Jan 27;11(2):274. doi: 10.3390/vaccines11020274.
3
A Rare Case of Dilated Cardiomyopathy, Focal Segmental Glomerulosclerosis, and Bell's Palsy in a 29-Year-Old Male After Coxsackievirus Infection.一名29岁男性在感染柯萨奇病毒后出现扩张型心肌病、局灶节段性肾小球硬化和贝尔麻痹的罕见病例。
Cureus. 2022 Jun 24;14(6):e26285. doi: 10.7759/cureus.26285. eCollection 2022 Jun.
4
Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.携带 CAR 相互作用区突变的柯萨奇 B3 病毒减毒株可预防心肌炎和胰腺炎。
Sci Rep. 2021 Jun 14;11(1):12432. doi: 10.1038/s41598-021-90434-w.
5
Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.柯萨奇病毒B3感染中心脏损伤的复杂性:对治疗的启示
Int J Cardiol. 2014 Dec 15;177(2):330-339. doi: 10.1016/j.ijcard.2014.09.136. Epub 2014 Oct 18.
6
Proinflammatory effects of interferon gamma in mouse adenovirus 1 myocarditis.γ干扰素在鼠腺病毒 1 型心肌炎中的促炎作用。
J Virol. 2015 Jan;89(1):468-79. doi: 10.1128/JVI.02077-14. Epub 2014 Oct 15.
7
Relevance of molecular mimicry in the mediation of infectious myocarditis.分子模拟在传染性心肌炎发病机制中的相关性。
J Cardiovasc Transl Res. 2014 Mar;7(2):165-71. doi: 10.1007/s12265-013-9519-3. Epub 2013 Nov 22.
8
Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling.柯萨奇病毒 B3 通过白细胞介素-1 信号诱导广泛的炎症相关基因。
Med Microbiol Immunol. 2013 Feb;202(1):11-23. doi: 10.1007/s00430-012-0245-2. Epub 2012 Jun 3.